Qube Research & Technologies Ltd
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1729829
LONDON, X0
Position in LGND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,515,119
+$6,604,765 QoQ
Shares Held
47,659
+209.6% QoQ
Ownership
0.239%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in LGND
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,515,119 | 47,659 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,910,354 | 15,393 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $643,372 | 3,632 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,055,902 | 18,085 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $530,957 | 5,050 | Shares | Sole | 2025-05-15 | |
| 2024-03-31 | $5,774 | 79 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,046,945 | 14,659 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,412,019 | 40,254 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,127,932 | 15,644 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $386,042 | 5,248 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $251,635 | 3,767 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $690,774 | 8,022 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,862,109 | 20,871 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $839,063 | 7,459 | Shares | Sole | 2022-05-09 | |
| 2020-06-30 | $1,730,095 | 15,468 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||